πŸ‡ΊπŸ‡Έ FDA
Patent

US 8242160

Inhibitors of ubiquitin E1

granted A61PA61P29/00A61P31/12

Quick answer

US patent 8242160 (Inhibitors of ubiquitin E1) held by The United States of America, as represented by the Secretary, Department of Health and Human Services expires Mon Aug 09 2032 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America, as represented by the Secretary, Department of Health and Human Services
Grant date
Tue Aug 14 2012 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Aug 09 2032 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
3
CPC classes
A61P, A61P29/00, A61P31/12, A61P31/18, A61P35/00